Boston Scientific Corp. (BSX) Tuesday said its surgical leads - CoverEdge 32 and CoverEdge X 32 - have received U.S. Food and Drug Administration approval as well as the CE Mark from European Union to provide software-guided stimulation to the spinal cord for relieving pain.
The company said CoverEdge 32 and CoverEdge X were superior to existing surgical leads as they have double the number of stimulating contacts.
The surgical leads will be presented at the Congress of Neurological Surgeons this week.
For comments and feedback contact: editorial@rttnews.com